NPI: 1528439395 · VISALIA, CA 93292 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,776 | $579K |
| 2019 | 7,334 | $607K |
| 2020 | 13,557 | $1.18M |
| 2021 | 11,853 | $1.49M |
| 2022 | 12,569 | $1.56M |
| 2023 | 22,939 | $2.01M |
| 2024 | 18,555 | $1.36M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 66,921 | 4,539 | $7.67M | |
| 90945 | 9,002 | 335 | $934K | |
| A4657 | Syringe w/wo needle | 4,777 | 1,460 | $54K |
| 0250 | 3,955 | 381 | $49K | |
| Q4081 | Epoetin alfa, 100 units esrd | 3,514 | 409 | $36K |
| J0887 | Epoetin beta esrd use | 851 | 623 | $22K |
| J1756 | Iron sucrose injection | 2,158 | 837 | $16K |
| 83970 | 541 | 526 | $627.65 | |
| G0008 | Admin influenza virus vac | 168 | 164 | $301.46 |
| 90674 | 81 | 78 | $280.64 | |
| 82728 | 400 | 378 | $224.77 | |
| 90662 | 28 | 28 | $198.92 | |
| 83540 | 426 | 400 | $133.01 | |
| 90661 | 22 | 22 | $76.37 | |
| G0499 | Hepb screen high risk indiv | 80 | 66 | $63.26 |
| 85041 | 604 | 570 | $59.47 | |
| 85048 | 587 | 552 | $50.32 | |
| J1270 | Injection, doxercalciferol | 1,182 | 147 | $39.47 |
| 83550 | 189 | 176 | $36.30 | |
| 82306 | 38 | 37 | $24.79 | |
| 82108 | 28 | 28 | $19.72 | |
| 82607 | 31 | 31 | $13.33 |